Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 3
2007 4
2008 3
2009 3
2010 4
2011 6
2012 3
2013 6
2014 5
2015 6
2016 11
2017 12
2018 11
2019 15
2020 23
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
The Clinical Perspective on Hepatitis E.
Horvatits T, Schulze Zur Wiesch J, Lütgehetmann M, Lohse AW, Pischke S. Horvatits T, et al. Among authors: schulze zur wiesch j. Viruses. 2019 Jul 5;11(7):617. doi: 10.3390/v11070617. Viruses. 2019. PMID: 31284447 Free PMC article. Review.
Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients.
Brehm TT, Franz M, Hüfner A, Hertling S, Schmiedel S, Degen O, Kreuels B, Schulze Zur Wiesch J. Brehm TT, et al. Among authors: schulze zur wiesch j. Medicine (Baltimore). 2019 Aug;98(32):e16721. doi: 10.1097/MD.0000000000016721. Medicine (Baltimore). 2019. PMID: 31393378 Free PMC article. Clinical Trial.
Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study.
Berg T, Simon KG, Mauss S, Schott E, Heyne R, Klass DM, Eisenbach C, Welzel TM, Zachoval R, Felten G, Schulze-Zur-Wiesch J, Cornberg M, Op den Brouw ML, Jump B, Reiser H, Gallo L, Warger T, Petersen J; FINITE CHB study investigators [First investigation in stopping TDF treatment after long-term virological suppression in HBeAg-negative chronic hepatitis B]. Berg T, et al. Among authors: schulze zur wiesch j. J Hepatol. 2017 Nov;67(5):918-924. doi: 10.1016/j.jhep.2017.07.012. Epub 2017 Jul 21. J Hepatol. 2017. PMID: 28736139 Clinical Trial.
Clinical Management of Ebola Virus Disease in the United States and Europe.
Uyeki TM, Mehta AK, Davey RT Jr, Liddell AM, Wolf T, Vetter P, Schmiedel S, Grünewald T, Jacobs M, Arribas JR, Evans L, Hewlett AL, Brantsaeter AB, Ippolito G, Rapp C, Hoepelman AI, Gutman J; Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe. Uyeki TM, et al. N Engl J Med. 2016 Feb 18;374(7):636-46. doi: 10.1056/NEJMoa1504874. N Engl J Med. 2016. PMID: 26886522 Free PMC article.
Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
Schäfer G, Hoffmann C, Arasteh K, Schürmann D, Stephan C, Jensen B, Stoll M, Bogner JR, Faetkenheuer G, Rockstroh J, Klinker H, Härter G, Stöhr A, Degen O, Freiwald E, Hüfner A, Jordan S, Schulze Zur Wiesch J, Addo M, Lohse AW, van Lunzen J, Schmiedel S; IDEAL study group. Schäfer G, et al. Among authors: schulze zur wiesch j. AIDS Res Ther. 2019 Nov 15;16(1):34. doi: 10.1186/s12981-019-0250-2. AIDS Res Ther. 2019. PMID: 31729999 Free PMC article. Clinical Trial.
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections.
Dietz J, Spengler U, Müllhaupt B, Schulze Zur Wiesch J, Piecha F, Mauss S, Seegers B, Hinrichsen H, Antoni C, Wietzke-Braun P, Peiffer KH, Berger A, Matschenz K, Buggisch P, Backhus J, Zizer E, Boettler T, Neumann-Haefelin C, Semela D, Stauber R, Berg T, Berg C, Zeuzem S, Vermehren J, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Among authors: schulze zur wiesch j. Clin Gastroenterol Hepatol. 2019 Nov 6:S1542-3565(19)31260-1. doi: 10.1016/j.cgh.2019.10.051. Online ahead of print. Clin Gastroenterol Hepatol. 2019. PMID: 31706062
Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes.
Heide J, Vaughan KC, Sette A, Jacobs T, Schulze Zur Wiesch J. Heide J, et al. Among authors: schulze zur wiesch j. Front Immunol. 2019 Mar 21;10:397. doi: 10.3389/fimmu.2019.00397. eCollection 2019. Front Immunol. 2019. PMID: 30949162 Free PMC article. Review.
HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage.
Muscate F, Stetter N, Schramm C, Schulze Zur Wiesch J, Bosurgi L, Jacobs T. Muscate F, et al. Among authors: schulze zur wiesch j. Front Immunol. 2018 Nov 13;9:2611. doi: 10.3389/fimmu.2018.02611. eCollection 2018. Front Immunol. 2018. PMID: 30483269 Free PMC article.
No link between male infertility and HEV genotype 3 infection.
Horvatits T, Varwig-Janssen D, Schulze Zur Wiesch J, Lübke R, Reucher S, Frerk S, Addo MM, Schneider SW, Lohse AW, Luetgehetmann M, Pischke S. Horvatits T, et al. Among authors: schulze zur wiesch j. Gut. 2020 Jun;69(6):1150-1151. doi: 10.1136/gutjnl-2019-319027. Epub 2019 May 22. Gut. 2020. PMID: 31118248 No abstract available.
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
Pflüger LS, Bannasch JH, Brehm TT, Pfefferle S, Hoffmann A, Nörz D, van der Meirschen M, Kluge S, Haddad M, Pischke S, Hiller J, Addo MM, Lohse AW, Schulze Zur Wiesch J, Peine S, Aepfelbacher M, Lütgehetmann M. Pflüger LS, et al. Among authors: schulze zur wiesch j. J Clin Virol. 2020 Sep;130:104549. doi: 10.1016/j.jcv.2020.104549. Epub 2020 Jul 17. J Clin Virol. 2020. PMID: 32763809 Free PMC article.
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback